Abatacept/Maltose
Brand name: Orencia
Rank #450 of 500 drugs by total cost
$17.2M
Total Cost
3,809
Total Claims
$17.2M
Total Cost
134
Prescribers
$4,521
Cost per Claim
245
Beneficiaries
3,905
30-Day Fills
$129K
Avg Cost/Provider
28
Avg Claims/Provider
About Abatacept/Maltose
Abatacept/Maltose (sold as Orencia) was prescribed 3,809 times by 134 Medicare Part D providers in 2023, costing the program $17.2M. At $4,521 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 447 | Anastrozole (Anastrozole) | $17.4M | 626,025 |
| 448 | Naproxen (Naproxen) | $17.4M | 903,928 |
| 449 | Vedolizumab (Entyvio) | $17.4M | 2,034 |
| 450 | Abatacept/Maltose (Orencia) | $17.2M | 3,809 |
| 451 | Potassium Citrate (Potassium Citrate Er) | $17.1M | 131,481 |
| 452 | Insulin Degludec/Liraglutide (Xultophy 100-3.6) | $17.1M | 10,644 |
| 453 | Dicyclomine Hcl (Dicyclomine Hcl) | $17.0M | 738,543 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology